Patent application number | Description | Published |
20080284403 | High-side current sense circuit with common-mode voltage reduction - A high-side current sense circuit comprises a sense resistance R | 11-20-2008 |
20120130654 | ELECTRICAL NETWORKS AND METHODS OF FORMING THE SAME - Electrical networks are formed to produce an approximation of at least one desired performance characteristic, based on the recognition that fabrication variations introduce slight differences in electronic sub-networks which were intended to be identical. These fabrication differences are turned to an advantage by providing a pool of sub-networks, and then selectively connecting particular combinations of these sub-networks to implement networks that approximate the desired performance characteristics. The sub-networks are of like kind (e.g., resistors) and have a like measure. | 05-24-2012 |
20140077862 | ELECTRICAL NETWORKS AND METHODS OF FORMING THE SAME - Electrical networks are formed to produce an approximation of at least one desired performance characteristic, based on the recognition that fabrication variations introduce slight differences in electronic sub-networks which were intended to be identical. These fabrication differences are turned to an advantage by providing a pool of sub-networks, and then selectively connecting particular combinations of these sub-networks to implement networks that approximate the desired performance characteristics. The sub-networks are of like kind (e.g., resistors) and have a like measure. | 03-20-2014 |
20140285167 | AUTO-TUNING SWITCHING REGULATOR - In an example, a system and method are disclosed for providing a single control law that is operable to regulate both small-signal, steady-state operation, and large-signal transients of a switching regulator. The control law is based on detecting a zero-crossing of capacitor current, and projecting in advance a turning point for either ramping up or ramping down capacitor voltage at a target voltage. Certain embodiments may realize the control function in high-speed analog components, although certain other embodiments may implement the same or a similar control law in a digital controller. | 09-25-2014 |
Patent application number | Description | Published |
20100204046 | Processes for the Control of Undesired Vegetation - Improved agricultural processes for the controlled cultivation of crops are disclosed. In one aspect, crops of different types, namely that is to say crops grown from seeds, plants or cultivars having resistance to two (or more) different classes of herbicides, are treated to control undesired vegetative growth using a single class of herbicides. | 08-12-2010 |
20120021911 | Plant Treatment Compositions and Methods for Their Use - Plant treatment compositions comprising metal alginate salts and at least one amine compound are useful in the treatment of plants, particularly food crops. The metal alginate salts are found to be highly effective in the absence of herbicides, fungicides and pesticides. | 01-26-2012 |
20130172184 | Plant Treatment Compositions and Methods for their Use - Plant treatment compositions comprising metal alginate salts and further containing at least one amine compound (sometimes also herein referred to as the “first amine compound”), and additionally includes at least a pH buffer composition comprising a second amine compound (sometimes also herein referred to as the “second amine compound”), which compositions useful in the treatment of plants, particularly food crops. In certain embodiments, the plant treatment compositions are highly effective even wherein the content of metallic copper present is 500 ppm or even less in the plant treatment composition used to treat plants or crops. The plant treatment compositions are found to be highly effective even in the absence of herbicides, fungicides and pesticides. | 07-04-2013 |
20130184157 | Improved Processes for the Control of Undesired Vegetative Growth In Crops - Disclosed are compositions comprising a microencapsulated triallate compound, and an improved process for the control of undesired vegetative growth in and among desired vegetative growth, especially cereal crops, the process comprising the steps of: providing an effective amount of a treatment composition to the treated crop. | 07-18-2013 |
20140213544 | Plant Treatment Compositions and Methods for Their Use - Plant treatment compositions comprising metal alginate salts and at least one amine compound are useful in the treatment of plants, particularly food crops. The metal alginate salts are found to be highly effective in the absence of herbicides, fungicides and pesticides. | 07-31-2014 |
Patent application number | Description | Published |
20120154585 | INTEGRATED ANTENNA SYSTEM FOR IMAGING MICROSATELLITES - Examples of imaging microsatellites are described that have an imaging system and antenna system disposed within the microsatellite body when the microsatellite is in a non-deployed state. The properties of the antenna system can be adjusted such that the antenna system does not impact, contact, or displace the imaging system when the microsatellite is in the non-deployed state. The properties of the antenna system can be adjusted such that the antenna system does not contact or impact the body of the microsatellite or any other structure when the microsatellite transitions to a deployed state. The antenna system can be configured to achieve a desired gain and/or data transmission rate by adjusting properties of the antenna system based on the radiation pattern of an antenna feed and geometric constraints imposed by the imaging system. Examples of methods for designing such imaging microsatellites are provided. | 06-21-2012 |
20120300071 | INTEGRATED ANTENNA SYSTEM FOR IMAGING MICROSATELLITES - Examples of imaging microsatellites are described that have an imaging system and antenna system disposed within the microsatellite body when the microsatellite is in a non-deployed state. The properties of the antenna system can be adjusted such that the antenna system does not impact, contact, or displace the imaging system when the microsatellite is in the non-deployed state. The properties of the antenna system can be adjusted such that the antenna system does not contact or impact the body of the microsatellite or any other structure when the microsatellite transitions to a deployed state. The antenna system can be configured to achieve a desired gain and/or data transmission rate by adjusting properties of the antenna system based on the radiation pattern of an antenna feed and geometric constraints imposed by the imaging system. Examples of methods for designing such imaging microsatellites are provided. | 11-29-2012 |
20140015970 | INTEGRATED ANTENNA SYSTEM FOR IMAGING MICROSATELLITES - Examples of imaging microsatellites are described that have an imaging system and antenna system disposed within the microsatellite body when the microsatellite is in a non-deployed state. The properties of the antenna system can be adjusted such that the antenna system does not impact, contact, or displace the imaging system when the microsatellite is in the non-deployed state. The properties of the antenna system can be adjusted such that the antenna system does not contact or impact the body of the microsatellite or any other structure when the microsatellite transitions to a deployed state. The antenna system can be configured to achieve a desired gain and/or data transmission rate by adjusting properties of the antenna system based on the radiation pattern of an antenna feed and geometric constraints imposed by the imaging system. Examples of methods for designing such imaging microsatellites are provided. | 01-16-2014 |
20140160286 | INTEGRATED ANTENNA SYSTEM FOR IMAGING MICROSATELLITES - Examples of imaging microsatellites are described that have an imaging system and antenna system disposed within the microsatellite body when the microsatellite is in a non-deployed state. The properties of the antenna system can be adjusted such that the antenna system does not impact, contact, or displace the imaging system when the microsatellite is in the non-deployed state. The properties of the antenna system can be adjusted such that the antenna system does not contact or impact the body of the microsatellite or any other structure when the microsatellite transitions to a deployed state. The antenna system can be configured to achieve a desired gain and/or data transmission rate by adjusting properties of the antenna system based on the radiation pattern of an antenna feed and geometric constraints imposed by the imaging system. Examples of methods for designing such imaging microsatellites are provided. | 06-12-2014 |
Patent application number | Description | Published |
20090281028 | OSK1 peptide analogs and pharmaceutical compositions - Disclosed is a composition of matter comprising an OSK1 peptide analog, and in some embodiments, a pharmaceutically acceptable salt thereof. A pharmaceutical composition comprises the composition and a pharmaceutically acceptable carrier. Also disclosed are DNAs encoding the inventive composition of matter, an expression vector comprising the DNA, and host cells comprising the expression vector. Methods of treating an autoimmune disorder and of preventing or mitigating a relapse of a symptom of multiple sclerosis are also disclosed. | 11-12-2009 |
20090291885 | Conjugated toxin peptide therapeutic agents - Disclosed is a composition of matter comprising an OSK1 peptide analog, and in some embodiments, a pharmaceutically acceptable salt thereof. A pharmaceutical composition comprises the composition and a pharmaceutically acceptable carrier. Also disclosed are DNAs encoding the inventive composition of matter, an expression vector comprising the DNA, and host cells comprising the expression vector. Methods of treating an autoimmune disorder and of preventing or mitigating a relapse of a symptom of multiple sclerosis are also disclosed. | 11-26-2009 |
20090297520 | Methods of using conjugated toxin peptide therapeutic agents - Disclosed is a composition of matter comprising an OSK1 peptide analog, and in some embodiments, a pharmaceutically acceptable salt thereof. A pharmaceutical composition comprises the composition and a pharmaceutically acceptable carrier. Also disclosed are DNAs encoding the inventive composition of matter, an expression vector comprising the DNA, and host cells comprising the expression vector. Methods of treating an autoimmune disorder and of preventing or mitigating a relapse of a symptom of multiple sclerosis are also disclosed. | 12-03-2009 |
20090299044 | DNA encoding chimeric toxin peptide fusion proteins and vectors and mammalian cells for recombinant expression - Disclosed is a composition of matter comprising an OSK1 peptide analog, and in some embodiments, a pharmaceutically acceptable salt thereof. A pharmaceutical composition comprises the composition and a pharmaceutically acceptable carrier. Also disclosed are DNAs encoding the inventive composition of matter, an expression vector comprising the DNA, and host cells comprising the expression vector. Methods of treating an autoimmune disorder and of preventing or mitigating a relapse of a symptom of multiple sclerosis are also disclosed. | 12-03-2009 |
20090305399 | DNA encoding OSK1 toxin peptide analogs and vectors and cells for combinant expression - Disclosed is a composition of matter comprising an OSK1 peptide analog, and in some embodiments, a pharmaceutically acceptable salt thereof. A pharmaceutical composition comprises the composition and a pharmaceutically acceptable carrier. Also disclosed are DNAs encoding the inventive composition of matter, an expression vector comprising the DNA, and host cells comprising the expression vector. Methods of treating an autoimmune disorder and of preventing or mitigating a relapse of a symptom of multiple sclerosis are also disclosed. | 12-10-2009 |
20090318341 | Methods of using OSK1 peptide analogs - Disclosed is a composition of matter comprising an OSK1 peptide analog, and in some embodiments, a pharmaceutically acceptable salt thereof. A pharmaceutical composition comprises the composition and a pharmaceutically acceptable carrier. Also disclosed are DNAs encoding the inventive composition of matter, an expression vector comprising the DNA, and host cells comprising the expression vector. Methods of treating an autoimmune disorder and of preventing or mitigating a relapse of a symptom of multiple sclerosis are also disclosed. | 12-24-2009 |
20110045587 | TOXIN PEPTIDE THERAPEUTIC AGENTS - Disclosed is a DNA encoding a composition of matter of the formula | 02-24-2011 |
20120009205 | Modified Fc Molecules - Disclosed is a process for preparing a pharmacologically active compound, in which at least one internal conjugation site of an Fc domain sequence is selected that is amenable to conjugation of an additional functional moiety by a defined conjugation chemistry through the side chain of an amino acid residue at the conjugation site. An appropriate amino acid residue for conjugation may be present in a native Fc domain at the conjugation site or may be added by insertion (i.e., between amino acids in the native Fc domain) or by replacement (i.e., removing amino acids and substituting different amino acids). In the latter case, the number of amino acids added need not correspond to the number of amino acids removed from the previously existing Fc domain. This technology may be used to produce useful compositions of matter and pharmaceutical compositions containing them. A DNA encoding the inventive composition of matter, an expression vector containing the DNA, and a host cell containing the expression vector are also disclosed. | 01-12-2012 |
20120121591 | SELECTIVE AND POTENT PEPTIDE INHIBITORS OF Kv1.3 - Disclosed are compositions of matter having an amino acid sequence of SEQ ID NO:4, or a pharmaceutically acceptable salt thereof, including embodiments comprising a toxin peptide analog related to ShK, HmK, and AETX-K and pharmaceutical compositions or medicaments containing them along with a pharmaceutically acceptable carrier. Some embodiments include a half-life extending moiety. Also disclosed are a method of preventing or mitigating a relapse of a symptom of multiple sclerosis and a method of treating an autoimmune disorder using the compositions. | 05-17-2012 |
20130189737 | DIPEPTIDES TO ENHANCE YIELD AND VIABILITY FROM CELL CULTURES - The present invention relates to the culture of animal cells in serum-free culture medium. The present invention provides particular dipeptides that can improve recombinant protein production and cell viability in such cultures, especially in the absence of peptones. | 07-25-2013 |
20130203659 | GLP-1 COMPOUNDS - GLP-1 compounds comprising GLP-1 analogs and methods of using the GLP-1 compounds for treating metabolic disorders, enhancing insulin expression, and promoting insulin secretion in a patient are provided. | 08-08-2013 |
20140073577 | POTENT AND SELECTIVE INHIBITORS OF NAV1.3 AND NAV1.7 - Disclosed is a composition of matter comprising an isolated polypeptide, which is a peripherally-restricted Nav1.7 inhibitor. In some disclosed embodiments, the isolated polypeptide is an inhibitor of Nav1.7 and/or Nav1.3. Other embodiments are conjugated embodiments of the inventive composition of matter and pharmaceutical compositions containing the inventive composition of matter. Isolated nucleic acids encoding some embodiments of inventive polypeptides and expression vectors, and recombinant host cells containing them are disclosed. A method of treating or preventing pain is also disclosed. | 03-13-2014 |
20150023988 | POTENT AND SELECTIVE INHIBITORS OF NAV1.7 - Disclosed is a composition of matter comprising an isolated polypeptide, which is a peripherally-restricted Na | 01-22-2015 |
20160000932 | MODIFIED Fc MOLECULES - Disclosed is a process for preparing a pharmacologically active compound, in which at least one internal conjugation site of an Fc domain sequence is selected that is amenable to conjugation of an additional functional moiety by a defined conjugation chemistry through the side chain of an amino acid residue at the conjugation site. An appropriate amino acid residue for conjugation may be present in a native Fc domain at the conjugation site or may be added by insertion (i.e., between amino acids in the native Fc domain) or by replacement (i.e., removing amino acids and substituting different amino acids). In the latter case, the number of amino acids added need not correspond to the number of amino acids removed from the previously existing Fc domain. This technology may be used to produce useful compositions of matter and pharmaceutical compositions containing them. A DNA encoding the inventive composition of matter, an expression vector containing the DNA, and a host cell containing the expression vector are also disclosed. | 01-07-2016 |
20160024159 | POTENT AND SELECTIVE INHIBITORS OF NAV1.7 - Disclosed is a composition of matter comprising an isolated polypeptide, which is a peripherally-restricted Na | 01-28-2016 |
20160067347 | APJ RECEPTOR AGONISTS AND USES THEREOF - The application is directed to APJ receptor agonist analogs having increased stability relative to the wild type apelin-13 and methods of using the agonist analogs. The analogs can be used, inter alia, in cardiac disorders such as heart failure. | 03-10-2016 |
Patent application number | Description | Published |
20160075851 | SILVER NANOPLATE COMPOSITIONS AND METHODS - Embodiments of the present invention relate to methods for preparing high optical density solutions of nanoparticle, such as nanoplates, silver nanoplates or silver platelet nanoparticles, and to the solutions and substrates prepared by the methods. The process can include the addition of stabilizing agents (e.g., chemical or biological agents bound or otherwise linked to the nanoparticle surface) that stabilize the nanoparticle before, during, and/or after concentration, thereby allowing for the production of a stable, high optical density solution of silver nanoplates. The process can also include increasing the concentration of silver nanoplates within the solution, and thus increasing the solution optical density. | 03-17-2016 |
20160101130 | SILVER NANOPLATE COMPOSITIONS AND METHODS - Embodiments of the present invention relate to methods for preparing high optical density solutions of nanoplates, such as silver nanoplates or silver platelet nanoparticles, and to nanoparticles, solutions and substrates prepared by said methods. The process can include the addition of stabilizing agents (e.g., chemical or biological agents bound or otherwise linked to the nanoparticle surface) that stabilize the nanoparticle before, during, and/or after concentration, thereby allowing for the production of a stable, high optical density solution of silver nanoplates. The process can also include increasing the concentration of silver nanoplates within the solution, and thus increasing the solution optical density. | 04-14-2016 |
Patent application number | Description | Published |
20140105982 | SILVER NANOPLATE COMPOSITIONS AND METHODS - Embodiments of the present invention relate to methods for preparing high optical density solutions of nanoplates, such as silver nanoplates or silver platelet nanoparticles, and to nanoparticles, solutions and substrates prepared by said methods. The process can include the addition of stabilizing agents (e.g., chemical or biological agents bound or otherwise linked to the nanoparticle surface) that stabilize the nanoparticle before, during, and/or after concentration, thereby allowing for the production of a stable, high optical density solution of silver nanoplates. The process can also include increasing the concentration of silver nanoplates within the solution, and thus increasing the solution optical density. | 04-17-2014 |
20150225599 | SILVER NANOPLATE COMPOSITIONS AND METHODS - Embodiments of the present invention relate to methods for preparing high optical density solutions of nanoparticle, such as nanoplates, silver nanoplates or silver platelet nanoparticles, and to the solutions and substrates prepared by the methods. The process can include the addition of stabilizing agents (e.g., chemical or biological agents bound or otherwise linked to the nanoparticle surface) that stabilize the nanoparticle before, during, and/or after concentration, thereby allowing for the production of a stable, high optical density solution of silver nanoplates. The process can also include increasing the concentration of silver nanoplates within the solution, and thus increasing the solution optical density. | 08-13-2015 |
Patent application number | Description | Published |
20100175124 | METHODS AND APPARATUS FOR IMPLEMENTING A SEARCH TREE - Apparatus and methods are provided for implementing a firewall in a network infrastructure component. A method comprises generating a search tree for a plurality of rules. The search tree comprises a first node having a first field bounds and a first set of rules of the plurality of rules, and a plurality of child nodes for the first node. Each child node has child field bounds based on an intersection of the first field bounds and the first set of rules, and each child node is assigned a respective subset of the first set of rules based on the respective child field bounds. The method further comprises receiving a first packet, identifying a first child node of the plurality of child nodes based on values for one or more fields of the first packet, and applying the respective subset of rules assigned to the first child node to the first packet. | 07-08-2010 |
20120110183 | DISTRIBUTED PROPAGATION OF DATA IN A WIRELESS COMMUNICATION NETWORK - A technique for distributed propagation of data in a wireless communication network includes providing | 05-03-2012 |
20120149367 | SYNCHRONIZATION OF MOBILE DEVICE INFORMATION IN A WIRELESS COMMUNICATION NETWORK - A technique for synchronization of mobile device information in a wireless communication network includes associating | 06-14-2012 |
20150281236 | DETECTION OF AN UNAUTHORIZED WIRELESS COMMUNICATION DEVICE - A technique for the detection of an unauthorized wireless communication device includes monitoring of Bluetooth® communications activity by a Bluetooth® capable communication device. Any monitored communication activity is analyzed against parameters that are predefined to detect suspected illegal activity. If illegal activity is suspected by the analysis, an alert is generated for a system administrator. The predefined parameters associate illegal activity with; data that includes credit card numbers and expiration dates, credit card transaction logging information, non-discoverable devices, activity after store hours, exceedingly long activity, etc. | 10-01-2015 |
20150371038 | LOCATING A WIRELESS COMMUNICATION ATTACK - A technique for locating a wireless communication attack includes monitoring of Bluetooth® communications activity by a Bluetooth® capable communication device. Any monitored communication activity is analyzed against parameters that are predefined to detect a communication attempt by a suspected criminal device to an illicit device. If the communication attempt by the suspected criminal device is detected by the analysis, a communication to the criminal device is controlled so as to delay completion of the communication to the criminal device in order to provide time to locate the criminal device. | 12-24-2015 |